Aladdin Mohammad: Baseline IgG as a Key Predictor of Hypogammaglobulinaemia in AAV
Aladdin Mohammad, Professor of Rheumatology at Lund University, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Frontiers, adding:
”I am pleased to share our latest publication: Hypogammaglobulinaemia in patients with ANCA-associated vasculitis treated with rituximab
Rituximab has become a cornerstone in the management of ANCA-associated vasculitis (AAV), but concerns remain regarding treatment-related hypogammaglobulinaemia and the associated risk of infections.
In this population-based Swedish cohort of patients with AAV treated with rituximab, we found that:
- Hypogammaglobulinaemia developed in 45% of patients.
- Most cases were mild to moderate.
- Lower baseline IgG levels independently predicted the development of hypogammaglobulinaemia.
- Hypogammaglobulinaemia was not associated with an increased risk of severe infections in this cohort.
These findings emphasize the importance of measuring IgG levels before initiating rituximab and monitoring them throughout treatment, particularly in patients with lower baseline IgG concentrations.
Many thanks to my co-authors Jens Rathmann, Hiba Kadhem, Mårten Segelmark, and David Jayne for their excellent collaboration.”
Title: Hypogammaglobulinaemia in patients with ANCA-associated vasculitis treated with rituximab
Authors: Jens Rathmann, Hiba Kadhem, Mårten Segelmark, David Jayne, Aladdin J. Mohammad
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 22, 2026, 03:05Sumyea Kabir: Jehovah’s Witnesses Update Their Position on Blood Components
-
Sep 22, 2026, 02:33Gerardo Moscatelli: The Spike Protein Cascade – From Endothelial Binding to Vascular Collapse
-
Sep 21, 2026, 20:56George Touma: ApoB Should Be Central to All Lipid Guidlines
-
Sep 21, 2026, 20:55Christopher Robinson: Obstetric Risks Are Seen at the Extremes of Birthweight
-
Sep 21, 2026, 20:54Emicizumab for Refractory GI Bleeding in Myeloma-Associated Acquired VWD – JTH
-
Sep 21, 2026, 20:52Ross Baker: ASH 2026 Guidelines on Iron Deficiency in HMB and Bleeding Disorders
-
Sep 21, 2026, 20:50Rainer Kaiser: Genes and Signalling Pathways Implicated in Procoagulant Platelet Generation
-
Sep 21, 2026, 20:49Natalia Dovlatova: Celebrating Stan Heptinstall and His Legacy in Platelet Science
-
Sep 21, 2026, 20:48Norm Roulet: The Interaction of Pb and SARS-CoV-2 and Its Impact on the Cardiovascular System